Constellium SE
NYSE:CSTMAluminum
+$0.32 today
- Market cap
- $2.88B
- Beta
- 1.54
- P/E (TTM)
- 10.7
- EPS (TTM)
- $3.17
Volume 1.46M
Average 2.27M
CSTM Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Constellium SENYSE: CSTM
Cost of Revenue · Q3 FY2026 · quarter ended Sep 2026
Cost of revenue grows 21.6% year over year
Q3 FY2026 cost of revenue of $2.35B rose 21.6% year over year. Sequentially, it fell 1.9% from the prior quarter. Over 3 fiscal years it compounded at +2.6% a year.
Context
- Cost of revenue amounted to 89.9% of revenue in FY2025, up 2.6 pp from a year earlier.
- Cost of revenue increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
Mixed currencies · from the income statement
- Latest · FY2025
- 7.59B USD
- Year-over-year change
- —
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.59B | — |
| FY2024 | 2024-12-31 | 6.18B | +0.4% |
| FY2023 | 2023-12-31 | 6.15B | -12.5% |
| FY2022 | 2022-12-31 | 7.03B | +13.2% |
| FY2021 | 2021-12-31 | 6.21B | — |
Cost of Revenue vs competitors
How CSTM compares with its peers on the latest reported figures
- Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
- Cost of revenue amounts to 86.9% of revenue for CSTM, versus a peer median of 74.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | R$32.33B BRL | -1.6% | +1.1% | 72.7% | |
| LTM Sep 2026 | $8.74B USD | — | +2.6% | 86.9% | |
| LTM Jun 2026 | $6.17B USD | +1.4% | -4.4% | 92.0% | |
| LTM Sep 2026 | $5.54B USD | +1.9% | -5.2% | 84.0% | |
| FY2026 | ZAR 5.04B ZAR | +6.2% | +8.9% | 47.0% | |
| LTM Jun 2026 | $3.66B USD | +31.4% | -1.4% | 88.5% | |
| LTM Sep 2026 | $2.26B USD | -1.2% | -6.0% | 75.3% | |
| LTM Jul 2026 | $1.77B USD | +26.6% | +1.8% | 84.4% | |
| LTM Jun 2026 | $1.3B USD | -5.9% | -6.5% | 70.6% | |
| LTM Jun 2026 | $597.2M USD | +94.5% | +23.8% | 57.1% | |
| LTM Jun 2026 | $507.79M USD | -25.7% | -2.7% | 42.9% | |
| Peer median (excluding CSTM) | — | +1.6% | -2.0% | 74.0% | |
Competitors are the stored peer set for CSTM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 · EUR | FY2022 Dec 2022 · EUR | FY2023 Dec 2023 · EUR | FY2024 Dec 2024 · EUR | FY2025 Dec 2025 · USD |
|---|---|---|---|---|---|
| Revenue | 6.97B | 7.93B | 7.11B | 7.08B | 8.45B |
| Cost of Revenue | 6.21B | 7.03B | 6.15B | 6.18B | 7.59B |
| Gross Profit | 751.79M | 894.89M | 958.68M | 905.83M | 857M |
| Gross Margin | 10.8% | 11.3% | 13.5% | 12.8% | 10.1% |
| Research & Development | 44.16M | 42.75M | 47.25M | 47.32M | 51M |
| Selling, General & Admin | 292.11M | 263.91M | 288.06M | 302.26M | 332M |
| Operating Expenses | 203.8M | 576.15M | 607.92M | 643.16M | 383M |
| Depreciation & Amortization | 302.3M | 287M | 275.07M | 293.57M | 330M |
| EBITDA | 802.74M | 518.39M | 583.12M | 523.41M | 852M |
| EBITDA Margin | 11.5% | 6.5% | 8.2% | 7.4% | 10.1% |
| Operating Income | 547.99M | 318.74M | 350.76M | 262.67M | 474M |
| Operating Margin | 7.9% | 4.0% | 4.9% | 3.7% | 5.6% |
| Interest Income | 0 | 0 | 16M | 0 | 0 |
| Interest Expense | 154.84M | 126.12M | 115M | 112M | 114M |
| Other Income / Expenses | (189.08M) | (179.35M) | (139.94M) | (132.3M) | (66M) |
| Income Before Tax | 358.91M | 139.39M | 210.82M | 130.37M | 408M |
| Pre-Tax Margin | 5.2% | 1.8% | 3.0% | 1.8% | 4.8% |
| Income Tax Expense | 62.27M | (153.33M) | 68.15M | 72.43M | 133M |
| Net Income | 290.98M | 286.22M | 138.12M | 54.08M | 273M |
| Net Margin | 4.2% | 3.6% | 1.9% | 0.8% | 3.2% |
| EPS (Basic) | 1.82 | 2.00 | 0.84 | 0.37 | 1.95 |
| EPS (Diluted) | 1.75 | 1.96 | 0.84 | 0.37 | 1.92 |
| Weighted Avg Shares | 141M | 143.63M | 148.81M | 145.49M | 139.68M |
| Weighted Avg Shares (Diluted) | 147.17M | 146.61M | 149.24M | 147.44M | 141.94M |
Constellium SE
NYSE:CSTM
Intrinsic Alpha fair value
Locked
Current Price
$21.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.